miglustat 100 MG Oral Capsule
- RxCUI
- 401938
- RxNorm name
- miglustat 100 MG Oral Capsule
- Display name
- miglustat 100 MG Oral Capsule
- Full name
- miglustat 100 MG Oral Capsule
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Miglustat | MIGLUSTAT | Navinta LLC | aa9a3ab6-2376-4b52-9e54-15dc87f25260 | 2025-12-31 | Warnings, Adverse reactions | 401938 |
| Yargesa | MIGLUSTAT | Edenbridge Pharmaceuticals LLC. | 2b371dfe-e2b0-47fe-b677-a7bde7149f87 | 2025-12-17 | Warnings, Adverse reactions | 401938 |
| MIGLUSTAT | MIGLUSTAT | ANI Pharmaceuticals, Inc. | d746749d-de15-4225-b806-59b0765d25ae | 2025-11-26 | Warnings, Adverse reactions | 401938 |
| Miglustat | MIGLUSTAT | Zydus Pharmaceuticals USA Inc. | b54cc8a0-2284-44c3-a8fa-d8aaa87a67c6 | 2025-03-17 | Warnings, Adverse reactions | 401938 |
| Miglustat | MIGLUSTAT | CoTherix, Inc. | 76eb7ac8-e0ee-4409-a4e7-e326c6725836 | 2023-04-25 | Warnings, Adverse reactions | 401938 |
| Zavesca | MIGLUSTAT | Actelion Pharmaceuticals US, Inc. | 817892d1-ee12-4632-85fc-57ccdf16d7b8 | 2023-04-20 | Warnings, Adverse reactions | 401938 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 817892d1-ee12-4632-85fc-57ccdf16d7b8 | migLUstat 100 MG Oral Capsule [PSN] · miglustat 100 MG Oral Capsule [SCD] | 2 | 19 | These highlights do not include all the information needed to use ZAVESCA safely and effectively. See full prescribing information for ZAVESCA. ZAVESCA ® (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | 20230420 |
| 76eb7ac8-e0ee-4409-a4e7-e326c6725836 | migLUstat 100 MG Oral Capsule [PSN] · miglustat 100 MG Oral Capsule [SCD] | 2 | 16 | These highlights do not include all the information needed to use miglustat safely and effectively. See full prescribing information for miglustat. miglustat capsules, for oral use Initial U.S. Approval: 2003 | 20230425 |
| d746749d-de15-4225-b806-59b0765d25ae | migLUstat 100 MG Oral Capsule [PSN] · miglustat 100 MG Oral Capsule [SCD] | 2 | 7 | These highlights do not include all the information needed to use MIGLUSTAT CAPSULES safely and effectively. See full prescribing information for MIGLUSTAT CAPSULES. MIGLUSTAT capsules, for oral use Initial U.S. Approval: 2003 | 20251126 |
| 2b371dfe-e2b0-47fe-b677-a7bde7149f87 | migLUstat 100 MG Oral Capsule [PSN] · miglustat 100 MG Oral Capsule [SCD] | 2 | 5 | These highlights do not include all the information needed to use YARGESA safely and effectively. See full prescribing information for YARGESA. YARGESA (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | 20251217 |
| aa9a3ab6-2376-4b52-9e54-15dc87f25260 | migLUstat 100 MG Oral Capsule [PSN] · miglustat 100 MG Oral Capsule [SCD] | 2 | 3 | These highlights do not include all the information needed to use MIGLUSTAT CAPSULES safely and effectively. See full prescribing information for MIGLUSTAT CAPSULES. MIGLUSTAT capsules, for oral use Initial U.S. Approval:2003 | 20251231 |
| b54cc8a0-2284-44c3-a8fa-d8aaa87a67c6 | migLUstat 100 MG Oral Capsule [PSN] · miglustat 100 MG Oral Capsule [SCD] | 2 | 1 | These highlights do not include all the information needed to use MIGLUSTAT CAPSULES safely and effectively. See full prescribing information for MIGLUSTAT CAPSULES. MIGLUSTAT capsules, for oral use Initial U.S. Approval: 2003 | 20250317 |